baber/WOPTO huggingface dataset:
Patent AU-700726-B2 (AU)
Title: Oxime ethers and their use as pesticides
Inventor: PFIFFNER ALBERT
IPC: C07C317/26
Filed: 1995-07-21
Granted: 1999-01-14
Abstract: Compounds of formula I are suitable for controlling and preventing infestation by microorganisms, insects and acarina on plants    <IMAGE>  (I)  and their possible isomers and mixtures of isomers, wherein a) X is CH2F or CHF2,  Y is CH and  Z is OCH3, or b) X is CH2F or CHF2,  Y is a nitrogen atom and  Z is OCH3 or NHCH3, and wherein R1 and R2 are each independently of the other hydrogen, cyano, C1-C12alkyl, halo-C1-C12alkyl, C2-C12alkenyl, C2-C12alkynyl, C3-C6cycloalkyl, cyclopropylmethyl, C1-C4alkoxy, C2-C12alkoxyalkyl, C1-C4alkoxycarbonyl, C1-C4alkylthio, C2-C5alkylthioalkyl; or an unsubstituted or mono- to tri-substituted ring having not more than 15 ring carbon atoms that may be multi-membered and that contains from 0 to 3 hetero atoms N, O or S, it being possible for that ring to be bonded via an aliphatic bridge having not more than 4 carbon atoms and/or via CO, oxygen or sulfur, as desired; or wherein R1 and R2 together with their common carbon atom form an unsubstituted or mono- to tri-substituted ring having not more than 15 ring carbon atoms that may be multi-membered and that contains from 0 to 3 hetero atoms N, O or S. They can be used in the form of commercially customary formulated compositions.
Patent AU-689939-B2 (AU)
Title: Process for the preparation of 1,1,1-trifluoroethane
Inventor: PENNETREAU PASCAL
IPC: C07C19/08
Filed: 1995-09-20
Granted: 1998-04-09
Abstract: Prepn. of 1,1,1-trifluoroethane(HFC-143a) comprises reacting vinylidene fluoride (VF2) with HF in the liq. phase without a catalyst.
Patent AU-578905-B2 (AU)
Title: Fiber optic interferometer transducer
Inventor: HICKS JOHN WILBUR JR
IPC: G01L1/24
Filed: 1984-08-20
Granted: 1988-11-10
Abstract: A sensor or transducer having a dual path optical fiber, such as a single mode, two polarization state, waveguide fiber, utilizes the relative change in propagation constant of the paths to sense and transduce an applied force to an interference variation and ultimately an electrical signal. In this arrangement, in-phase light is introduced to both polarized states or paths in the fiber and transmitted therealong past a stress area of birefringement inducing force and ultimately combined, thereby producing in the combined beam a variation in interference which is related to the applied force. Specific structures are provided for converting isotropic forces such as pressure and temperature to anisotropic forces on the fiber to thereby produce birefringement and to also magnify the latter effect.
Patent AU-776290-B2 (AU)
Title: Protection probes
Inventor: BRENTANO STEVEN T
IPC: C12Q1/6806
Filed: 2000-02-11
Granted: 2004-09-02
Abstract: The present invention features compositions and methods that are useful for storing labeled detection probes and detecting whether a target nucleic acid sequence is present in a sample. Preferred compositions are made up of a detection probe containing a label susceptible to a chemical or enzymatic alteration and a protection probe that protects the label from alteration and/or decreases the ability of the detection probe to inhibit nucleic acid amplification. Such compositions can be used, for example, to stabilize a detection probe label and to prevent a detection probe from hybridizing prematurely to amplified or target nucleic acid.
Patent AU-771700-B2 (AU)
Title: Method for producing 4-amino-5-chloro-1-phenyl pyridazinone-(6)
Inventor: MERKLE HANS RUPERT
IPC: C07D237/22
Filed: 2000-03-30
Granted: 2004-04-01
Abstract: In a process for preparing 4-amino-5-chloro-1-phenylpyridazin-6-one by reacting 4,5-dichloro-1-phenylpyridazin-6-one with aqueous ammonia in the presence of a catalyst, the catalyst used is soluble in the aqueous alkaline reaction medium but is essentially insoluble in the reaction medium which has been acidified after removal of the 4-amino-5-chloro-1-phenylpyridazin-6-one.The process of the present invention makes it possible for the catalyst to be recovered and reused in a simple manner.
Patent AU-782074-B2 (AU)
Title: Fastener closure arrangement for flexible packages
Inventor: KINIGAKIS PANAGIOTIS
IPC: B65D33/25
Filed: 2002-04-17
Granted: 2005-06-30
Abstract: A flexible package (200; 230; 240; 260; 270; 280) is provided with a shrouded slider fastener closure. A side seal (22) forming the package is enlarged (80) at its upper end to provide a smooth transition of product dispensed from the package, and to shield the slider (30) during dispensing. The enlarged side seal portion (80) is spaced from the fastener tracks (26, 28). The fastener tracks (26, 28) are deformed to provide a stop (68) spaced from the side seals (20, 22) to limit slider (30) movement. A stop (68) of reduced area, enlarging the package opening, is made possible. <IMAGE>
Patent AU-692929-B2 (AU)
Title: Priority queue filtering system and method of operation
Inventor: HOGGE JOHN C
IPC: G06F7/24
Filed: 1995-09-18
Granted: 1998-06-18
Abstract: A software system (2) utilizing a filtered priority queue (10) is provided. A filtering module (4) is operable to access a plurality of data records of entities (16, 18, 20, 22, 24, 26 and 28) of a priority queue and to filter and arrange the data records in a memory storage device (8) to form the filtered priority queue (10). The filtered priority queue (10) comprises a remaining set (12) and a filtered set (14). The filtered set (14) contains a first subset of data records (20, 22, 24, 26, and 28). The first subset of data records (20, 22, 24, 26, and 28) form sublevels of a lattice. The remaining set (12) contains a second subset of data records (16 and 18). The second subset of data records (16 and 18) comprise lattice heads of the lattice. A sorting module (6) is coupled to the filtering module (4). The sorting module (6) is operable to access the remaining set (12) and to order the data records (16 and 18) in the second subset of data records to identify a data record (16) of a most critical entity.
Patent AU-777843-B2 (AU)
Title: Moulding of mouldable materials
Inventor: TOIT PIETER WOUTER DU
IPC: B22F3/11
Filed: 2001-02-14
Granted: 2004-11-04
Abstract: A method of moulding and a moulding installation is disclosed. The installation comprises a compounder (16), a flow path (26) from the compounder to a vessel (34) in which the mouldable material emerging from the compounder is accumulated, and further flow paths (28) from the vessel (34) to a number of moulders (30) each of which is associated with a mould (32). The moulders take charges of mouldable material on a cyclical basis.
Patent AU-618378-B2 (AU)
Title: Derivatives of (1-hydroxy-2-piperidylalkyl)-indol-2-ones, 2-quinolinones, 2-benzo{b}azapinones, benzimidazol-2-ones, and quinazolin-2-ones, their preparation and their application in therapeutics
Inventor: FROST JONATHAN
IPC: C07D401/06
Filed: 1989-07-11
Granted: 1991-12-19
Abstract: Compounds corresponding to the general formula (I) 
<IMAGE>
 in which Z denotes a group of formula -CH2-, -C(CH3)2-, -CH=CH-, -(CH2)2-, -(CH2)3-, -NH- or -N(CH3)CH2-, R1 denotes a hydrogen atom or an alkyl group, R2 denotes a hydrogen atom or a methyl group, and R3 denotes either an optionally substituted phenoxy group or a naphthyloxy group or an optionally substituted phenylmethyl group, or a bis(4-fluorophenyl)methyl group or an optionally substituted phenylmethoxy group or a (2-naphthyl)methoxy group or an optionally substituted phenoxymethyl group or a pyridinyloxy group, and R4 denotes a hydrogen atom, or else R3 and R4 form together and with the piperidine ring a spiro(2,3-dihydro-2:4'-benzofuran-1-piperidinyl) group. Application in therapy.
Patent AU-780390-B2 (AU)
Title: Redox flow battery and method of operating it
Inventor: ZOCCHI ANDREA
IPC: H01M50/77
Filed: 2000-03-31
Granted: 2005-03-17
Abstract: By realizing or installing check valve liquid vein interrupters in each compartment of the battery the phenomenon of slow discharge of the retained volumes of electrolytes during long periods of inactivity of a redox flow battery, with the electrolyte pumps stopped altogether, can be practically eliminated with the effect that the battery is perfectly ready to deliver electric power immediately upon request even after prolonged periods of inactivity. Moreover, the presence of liquid vein interrupters on each compartment in either an outlet or an inlet port substantially preventing by-pass current during a not pumping phase, permits to increase the by pumping the electrolytes through the compartments of a battery stack intermittently, in other words in a pulsed manner, with a certain duty-cycle. Relatively brief pumping phases at relatively high flow rate alternated to phases of not pumping provide for a volumetrically adequate refreshing of the electrolytes present in the battery compartments and contrast the formation of gradients in the bodies of electrolyte.
Patent AU-668932-B2 (AU)
Title: Method of blocking sodium channels or neuronal tissue
Inventor: MACLEOD BERNARD A
IPC: A61K31/27
Filed: 1993-03-26
Granted: 1996-05-23
Abstract: This invention provides aminocyclohexylamides for use within methods of blocking sodium channels in cardiac or neuronal tissue and for use in the manufacture of medicaments to block sodium channels in cardiac or neuronal tissue. This invention also provides commercial kits comprising a pharmaceutical composition containing aminocyclohexylamides and, instructions for the use of the pharmaceutical composition for arrhythmia or for the inducement of local anaesthesia.
Patent AU-609634-B2 (AU)
Title: Process for the production of multipart printed products, printed product produced by this process, and device for carrying out the process
Inventor: REIST WALTER
IPC: B65H39/06
Filed: 1989-08-08
Granted: 1991-05-02
Abstract: A first inner part (18) is introduced at the first feeding station (38) into the receiving part (32) driven in a rotating manner in the conveying direction (F). At the second feeding station (40), the second inner part (20) is added, side by side against the first inner part (18). At the third feeding station (42), a folded outer part (12) with its open side edge (16) opposite the fold (14) to the front is placed over the inner parts (18, 20) collected in this way. The end product (10) thus formed has an outer part (12) and two inner parts (18, 20) arranged therein, the folds (26) of the inner parts (18, 20) extending along the side edge (16) of the outer part (12). 
<IMAGE>
Patent AU-749601-B2 (AU)
Title: A process for sterilizing a biologically contaminated enclosure
Inventor: RAHMAN SHOAA ABDUL
IPC: A01N35/02
Filed: 2000-03-28
Granted: 2002-06-27
Abstract: The present invention relates to a process for sterilizing a biologlically contaminated enclosure in which the enclosure is brought into contact with formaldehyde. Said formaldehyde is released from formalin by heat generated by an exothermic reaction occurring in the presence of said formalin. The exothermic reaction is provided by addition of a first reagent (A) and a second reagent (B) to said formalin in amounts sufficient to generated heat for releasing formaldehyde from said formalin. Said reagent (A) comprises hexamethylenetetramine and said second reagent (B) comprises a peroxide compound or a precursor thereof.
Patent AU-710513-B2 (AU)
Title: Therapeutic agent for disorder of lipid metabolism
Inventor: SHIOTA AKIRA
IPC: A61P3/06
Filed: 1995-12-27
Granted: 1999-09-23
Abstract: The present invention relates to a therapeutic agent for treatment of disorder of lipid metabolism comprising TCF-II as an effective ingredient. The therapeutic agent of the present invention is useful for treatment of disorder of lipid metabolism caused by diabetes, endocrinological diseases, such as thyroid dysfunction and adrenal dysfunction, chronic metabolism disorder, chronic renal failure including nephrosis, uremia, cancer, dyscrasia, adverted effects of antitumor agents, gastrointestinal (including hepatic and pancreatic) impairment and so on. Hypercholesterolemia, hypolipidemia or hypo-high-density-lipoproteinemia is exemplified as a disorder of lipid metabolism. The therapeutic agent of the present invention normalizes not only hyperlipidemia but also hypolipidemia. In addition, it improves fatty liver.
Patent AU-727177-B2 (AU)
Title: Purine L-nucleosides, analogs and uses thereof
Inventor: WANG GUANGYI
IPC: C07H19/04
Filed: 1997-10-15
Granted: 2000-12-07
Abstract: Novel purine L-nucleoside compounds are disclosed, in which both the purine rings and the sugar are either modified, functionalized, or both. The novel compounds or pharmaceutically acceptable esters or salts thereof may be used in pharmaceutical compositions, and such compositions may be used to treat an infection, an infestation, a neoplasm, or an autoimmune disease. The novel compounds may also be used to modulate aspects of the immune system, including modulation of Th1 and Th2.
Patent AU-590238-B2 (AU)
Title: Recombinant methods for production of serine protease inhibitors and dna sequences useful for same
Inventor: BANDYOPADHYAY PRADIP K
IPC: A01H/
Filed: 1985-12-04
Granted: 1989-11-02
Abstract: A synthetic DNA sequence and its genetic equivalents which sequencies are capable, when used in a recombinant DNA method, of directing production of a serine protease inhibitor protein. Recombinant DNA methods for the production of serine protease inhibitor proteins are also disclosed. These methods incorporate either the synthetic DNA sequence of the present invention or natural DNA sequences isolated from human cDNA or genomic libraries.
Patent AU-693673-B2 (AU)
Title: Magnetic antipilferage tag
Inventor: LIEVENS HUGO
IPC: G08B13/24
Filed: 1996-05-02
Granted: 1998-07-02
Abstract: An antipiliferage tag comprising a soft-magnetic thin film (100) for use as an active element in an electronic article surveillance (E.A.S.) system. The film (100) has an easy axis (102) with a particular direction. The tag has been folded along at least one folding line (104) so that the tag comprises at least two layers which at least partially overlap with each other. The folding line (104) forms an oblique angle different from zero with the direction of the easy axis (102) so that the direction of the easy axis (102) in one layer is different from the direction of the easy axis (106) in another layer. In this way an antipiliferage tag which is insensitive to its orientation in a detection gate of an E.A.S. system is obtained.
Patent AU-672646-B2 (AU)
Title: Resin laminate
Inventor: TANAKA HIROSHI
IPC: A61J1/10
Filed: 1993-12-24
Granted: 1996-10-10
Abstract: A resin laminate comprising: an outer layer formed from a linear polyethylene having a density from 0.910 to 0.950 g/cm<3>; an inner layer formed from a linear polyethylene having a density of not more than 0.940 g/cm<3>; and an intermediate layer or layers between the outer and inner layers, at least one intermediate layer comprising a linear polyethylene having a density not more than 0.920 g/cm<3>; at least one of the outer, inner and intermediate layers is formed from a linear polyethylene composition containing a high-density polyethylene and a container formed from the resin laminate. The resin laminate is excellent in hygienic qualities, transparency, flexibility and heat resistance.
Patent AU-639450-B2 (AU)
Title: Unsaturated aminodicarboxylic acid derivatives
IPC: C07F9/38
Filed: 1990-04-05
Granted: 1993-07-29
Abstract: Unsaturated aminodicarboxylic acid derivatives of formula (I) <IMAGE> in which A represents a divalent aliphatic hydrocarbon radical with 2 carbon atoms and R1 and R2 independently of each other represent free or esterified carboxyl groups, and their salts possess an outstanding and selective antagonistic effect on excitatorial amino acid receptors sensitive to N-methyl-D-aspartic acid. They are prepared for example by converting Z3 in a compound of formula II <IMAGE> in which Z1 and Z2 stand for optionally protected hydroxyl and Z3 represents protected amino, into amino and, if present, protected hydroxyl Z1 and/or Z2 into hydroxy, and if desired converting one compound obtained into another compound of formula I, an isomeric mixture obtainable using this method being separated into the components and the particular preferred isomer being separated out and/or a free compound obtainable using this method being converted into a salt or a salt obtainable using this method being converted into the free compound.
Patent AU-717133-B2 (AU)
Title: Process for producing tubular bodies
Inventor: KELLER GERHARD
IPC: B29D23/00
Filed: 1997-11-17
Granted: 2000-03-16
Abstract: In a method of manufacturing a multi-layered tubular products (8) with one or more interior, dividing walls forming adjacent longitudinal chambers, a tube (6) or cut tube section for forming a dividing wall is attached parallel to a film strip (1) or film strip section cut to length and then the side walls of the film strip or strip section are joined together to form a tube (8) around the tubular dividing wall creating two or more chambers (C,D,E). The completed tubular structure can then be cut to length or cut sections may be joined together to form a longer tube. Also claimed is a variation where a second dividing wall strip is attached to the film strip (1) and the first dividing wall so that when the film strip is joined at the ends three parallel chambers are created whose walls lie close together.
Patent AU-687016-B2 (AU)
Title: Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
Inventor: BARCLAY WILLIAM R
IPC: A23L13/00
Filed: 1993-10-12
Granted: 1998-02-19
Abstract: Disclosed is a process for growing the microflora  Thraustochytrium, Schizochytrium  and mixtures thereof, which includes the growing of the microflora in fermentation medium containing non-chloride containing sodium salts, in particular sodium sulfate. In a preferred embodiment of the present invention, the process produces microflora having a cell aggregate size useful for the production of food products for use in aquaculture. Further disclosed is a food product which includes  Thraustochytrium, Schizochytrium , and mixtures thereof, and a component selected from flaxseed, rapeseed, soybean and avocado meal. Such a food product includes a balance of long chain and short chain omega-3 highly unsaturated fatty acids.
Patent AU-698775-B2 (AU)
Title: Raw release papers with pigment coatings based on aluminium hydroxides
Inventor: REINHARDT BERND DR ING
IPC: D21H27/00
Filed: 1996-03-26
Granted: 1998-11-05
Abstract: PCT No. PCT/EP96/01319 Sec. 371 Date Mar. 24, 1998 Sec. 102(e) Date Mar. 24, 1998 PCT Filed Mar. 26, 1996 PCT Pub. No. WO96/31651 PCT Pub. Date Oct. 10, 1996Raw release paper for coating with a layer of dehesive silicone, in which case a pigment coating containing a binder is formed on the paper, exhibits aluminum hydroxide as the sole pigment or a pigment mixture with aluminum hydroxide as the main component.
Patent AU-748211-B2 (AU)
Title: Cosmetic composition comprising at least one silicone/ acrylate copolymer and at least one thickening agent
Inventor: DUPUIS CHRISTINE
IPC: A61K8/72
Filed: 2000-09-05
Granted: 2002-05-30
Abstract: The composition comprises silicone/acrylate copolymer A, obtained by radical polymerization of ethylenically unsaturated monomer (a) in presence of silicone derivative (b) comprising oxyalkylene groups, and non-cellulosic thickening agent B. Independent claims are also included for 1) process of maintaining or setting a hair style involving application of composition as claimed; 2) the use of composition as claimed for making cosmetic product for use on hair; and 3) use of composition as claimed for cosmetic treatment of skin, nails, lips, hair, eyebrows and eyelashes.
Patent AU-783451-B2 (AU)
Title: Flexible switching devices
Inventor: LUSSEY DAVID
IPC: H01H13/00
Filed: 2001-05-17
Granted: 2005-10-27
Abstract: An electronic resistor user interface comprises flexible conductive materials and a flexible variably resistive element capable of exhibiting a change in electrical resistance on mechanical deformation and is characterised by textile-form electrodes (10, 12), a textile form variably resistive element (14) and textile-form members (16) connective to external circuitry.
Patent AU-641403-B2 (AU)
Title: Method of treating catabolic, gut-associated pathological processes and impaired host defenses
Inventor: SMITH ROBERT J
IPC: A61P3/10
Filed: 1990-06-04
Granted: 1993-09-23
Abstract: Catabolic, gut-associated pathological processes, including intestinal mucosal and pancreatic atrophy and enhanced gut permeability, impairment of host defences and compromised immune function, can be treated, and recovery from bone marrow transplantation can be promoted by the administration of a therapeutically effective amount of glutamine or an analogue thereof.
Patent AU-590885-B2 (AU)
Title: Passivation process and composition for zinc-aluminum alloys
Inventor: REGHI GARY A
IPC: C23C22/38
Filed: 1986-06-16
Granted: 1989-11-23
Abstract: An aqueous acidic treating solution for forming a chromium-containing passivate coating on the surface of zinc or zinc-aluminium alloys contains chromium ions of which the predominant proportion are in the hexavalent state, preferably in an amount 2-20 g/l., nitrate ions, preferably in an amount 0.5-6 g/l., and phosphate ions, preferably in an amount 1-15 g/l. The solution may also contain fluoride ions, molybdate ions and tungstate ions. The phosphide may be an alkali metal or ammonium phosphate, a polyphosphate or phosphoric acid.
Patent AU-685778-B2 (AU)
Title: C2 taxane derivatives and pharmaceutical compositions containing them
Inventor: HOLTON ROBERT A
IPC: C07D407/12
Filed: 1994-01-28
Granted: 1998-01-29
Abstract: Taxane derivatives having alternative C2 substituent which is -OCOR31 wherein R31 is substituted phenyl and the substituent is selected from the group consisting of alkanoxy, protected hydroxy, halogen, alkyl, aryl, alkenyl, acyl, acyloxy, nitro, amino and amido.
Patent AU-618511-B2 (AU)
Title: Automatic blood pressure measurement in hyperbaric chamber
Inventor: LAVIOLA JOHN
IPC: A61B5/022
Filed: 1990-09-03
Granted: 1991-12-19
Abstract: Blood pressure measurements are performed on subjects disposed in hyperbaric chambers (14). The measurements are made by an automatic blood pressure monitoring instrument having a differential pressure transducer (4) component. The reference side of the pressure transducer is open to the pressure in the hyperbaric chamber. A rotary vane pump (16) is used to inflate the cuff (36) with the inflation fluid supply from within the hyperbaric chamber (14), and exhaust (8) from deflating the cuff is vented back into the hyperbaric chamber.